Will The Supply Shortage Weigh On Eli Lilly’s Q2?
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Eli Lilly stock (NYSE: LLY) will report its Q2 results on Thursday, August 8. The pharmaceutical giant is expected to garner $10 billion in sales and $2.70 in adjusted earnings per share, per the consensus estimates. All eyes will be on Eli Lilly’s diabetes drug – Mou
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-184827885-2--573b86c35f9b58723dbe24fa.jpg "<div>IPO vs. Staying Private: What's the Difference?</div>")
